Intermountain Healthcare has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare’s more pressing and enduring issues, drug shortages that disrupt patient care.
“National drug shortages have plagued providers and patients for years,” said Dan Liljenquist, chief strategy officer at Intermountain Healthcare, and board chair of Utah-based Civica Rx, which produces low-cost generic medications for about a third of all U.S. hospitals. “This Alliance will greatly help to find solutions that address this concern.”
The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply.
"We are grateful to have Intermountain Healthcare join the alliance to end drug shortages," said Eric Tichy, division chair of pharmacy supply solutions for Mayo Clinic, who serves as the chair for the Alliance advisory board. "Collaboration among organizations strengthens our ability to improve the quality of life for patients that rely on these medications. Together, we can make a difference."
Learn more at www.EndDrugShortages.com.
# # #